370
Participants
Start Date
August 31, 2001
Primary Completion Date
February 28, 2010
Study Completion Date
February 28, 2010
lacosamide
50mg and 100mg tablets up to 800 mg/day as twice a day (BID) dosing throughout the trial
Birmingham
Huntsville
Phoenix
Tucson
Little Rock
Los Angeles
Englewood
Gainesville
Hollywood
Miami
Ponte Vedra Beach
Chicago
Springfield
Indianapolis
Iowa City
Wichita
Crestview Hills
Lexington
Baltimore
Frederick
Boston
Ann Arbor
Detroit
Saint Paul
Chesterfield
St Louis
Somerset
New York
Durham
Cincinnati
Cleveland
Columbus
Hershey
Philadelphia
Nashville
Dallas
Irving
Lubbock
Wichita Falls
Bennington
Charlottesville
Marshfield
Milwaukee
Bonn
Erlangen
Kehl Kork
Schwalmstedt-Treysa
Budapest
Zalaegerszeg
Kaunas
Vilnius
Poznan
Gothenburg
Stockholm
Bern/Biel
Zurich
Bucks/London
Glasgow
Liverpool
Lead Sponsor
UCB Pharma
INDUSTRY